Trek Financial’s Nuvalent NUVL Stock Holding History

Trek Financial’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-24,195	Closed	-$2.48M	–	449
2024 Q3	$2.48M	Buy	+24,195	New	+$2.01M	0.19%	126

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Trek Financial's NUVL Position: Q4 2024 in Review

Trek Financial sold out of Nuvalent (NUVL) in Q4 2024, closing a stake of 24,195 shares — an estimated $2.48M sold.

Trek Financial first reported a position in NUVL in Q3 2024 and held it in 1 quarter. The position peaked at $2.48M in Q3 2024. 216 funds tracked by Wall St. Rank hold NUVL as of Q4 2024.

Trek Financial reported no remaining Nuvalent position as of Q4 2024 after selling out during the quarter.
Trek Financial sold 24,195 Nuvalent shares in Q4 2024, an estimated $2.48M.
Trek Financial first reported a position in Nuvalent in Q3 2024 and held it in 1 quarter.
Trek Financial's Nuvalent position peaked at $2.48M in Q3 2024.
216 funds tracked by Wall St. Rank held Nuvalent as of Q4 2024.

Based on Trek Financial's 13F filing for Q4 2024, filed 13 Feb 2025.